OmniAb (OABI) Current Taxes (2022 - 2023)
OmniAb (OABI) reported Current Taxes of $3.5 million for Q3 2023, little changed quarter-over-quarter from $3.5 million in Q2 2023.
OmniAb (OABI) Current Taxes (2022 - 2023) Analysis & Trends
OmniAb (OABI) has 2 years of Current Taxes data on file, last reported at $3.5 million in Q3 2023.
- Current Taxes for Q3 2023 came in at $3.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $3.5 million (changed N/A YoY), and the FY2022 annual result was $3.5 million, changed N/A from the prior year.
- Current Taxes held at $3.5 million in Q3 2023 per OABI's latest filing, from $3.5 million in the prior quarter.
- Over five years, Current Taxes peaked at $3.5 million in Q1 2023 and troughed at $3.5 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 3.46 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Dec 31, 2022 | 3.49 Mn |